Back
Cognition Therapeutics Stock Price Chart

Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.
Sell
22
CGTX
Cognition Therapeutics
Last Price:
$0.30
Seasonality Move:
-44.34%
7 Day Trial
ALL ACCESS PASS
$
7

The EXACT DAY Certain Stocks Soar - Year After Year
Find out now - completely free of charge.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGTX is experiencing slight buying pressure.
Cognition Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Buy |
20-day SMA: | 0.3 | Sell |
50-day SMA: | 0.35 | Sell |
200-day SMA: | 0.51 | Sell |
8-day EMA: | 0.29 | Buy |
20-day EMA: | 0.31 | Sell |
50-day EMA: | 0.36 | Sell |
200-day EMA: | 0.63 | Sell |
Cognition Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 44.31 | Sell |
Chaikin Money Flow: | -57940 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.37) | Sell |
Bollinger Bands (100): | (0.32 - 0.6) | Sell |
Cognition Therapeutics Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cognition Therapeutics Stock
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.30 while CGTX 8-day simple moving average is 0.28, which is a Buy signal.
-
The stock price of CGTX is 0.30 while Cognition Therapeutics 20-day SMA is 0.30, which makes it a Sell.
-
Cognition Therapeutics 50-day simple moving average is 0.35 while CGTX share price is 0.30, making it a Sell technically.
-
CGTX stock price is 0.30 and Cognition Therapeutics 200-day simple moving average is 0.51, creating a Sell signal.
CGTX Technical Analysis vs Fundamental Analysis
Sell
22
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a SellThe current Cognition Therapeutics [CGTX] share price is $0.30. The Score for CGTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Cognition Therapeutics Stock Info
Market Cap:
18.3M
Price in USD:
0.30
Share Volume:
944.4K
Cognition Therapeutics 52-Week Range
52-Week High:
2.54
52-Week Low:
0.22
Sell
22
Cognition Therapeutics (CGTX)
is a Sell
Cognition Therapeutics Share Price Forecast
-
What is the Cognition Therapeutics stock price today?The Cognition Therapeutics stock price is 0.30 USD today.
-
Will CGTX stock go up or go down?Cognition Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cognition Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cognition Therapeutics is overvalued.
Is Cognition Therapeutics Stock a Buy?
-
Cognition Therapeutics share price is 0.30 while CGTX 8-day exponential moving average is 0.29, which is a Buy signal.
-
The stock price of CGTX is 0.30 while Cognition Therapeutics 20-day EMA is 0.31, which makes it a Sell.
-
Cognition Therapeutics 50-day exponential moving average is 0.36 while CGTX share price is 0.30, making it a Sell technically.
-
CGTX stock price is 0.30 and Cognition Therapeutics 200-day simple moving average is 0.63, creating a Sell signal.
Fundamental Analysis of Cognition Therapeutics
Is Cognition Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.04 per share, an increase this year of $0.38 per share, and an increase next year of $0.13 per share.
Technical Analysis of Cognition Therapeutics
Should I short Cognition Therapeutics stock?
-
CGTX Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cognition Therapeutics is a Sell
-
Cognition Therapeutics Relative Strength Index (RSI) is 44.31, which suggest Cognition Therapeutics is oversold
-
The Bollinger Bands (25) for Cognition Therapeutics is (0.27 - 0.37), which suggest Cognition Therapeutics is a Sell
-
The Bollinger Bands (100) for Cognition Therapeutics is (0.32 - 0.6), which suggest Cognition Therapeutics is a Sell
* Cognition Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.